Attention-deficit/hyperactivity disorder: a therapeutic update.
Kirby
Kelly
K
Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts 02115, USA. kkirby@mcp.edu
Rutman
Lori E
LE
Bernstein
Henry
H
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D000529:Complementary Therapies; D003937:Diagnosis, Differential; D006801:Humans
D000317:Adrenergic alpha-Antagonists; D000929:Antidepressive Agents, Tricyclic; D000697:Central Nervous System Stimulants